SRL
ADMA icon

Scientech Research LLC’s ADMA Biologics ADMA Stock Holding History

Scientech Research LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,756
Closed -$214K – 231
2026
Q1 		$214K Buy
+23,756
New +$375K 0.18% 222
2025
Q4 		– Sell
-33,862
Closed -$496K – 485
2025
Q3 		$496K Sell
33,862
-3,954
-10% -$67.8K 0.17% 259
2025
Q2 		$689K Buy
+37,816
New +$771K 0.17% 253

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Scientech Research LLC's ADMA Position: Q2 2026 in Review

Scientech Research LLC sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 23,756 shares — an estimated $214K sold.

Scientech Research LLC first reported a position in ADMA in Q2 2025 and held it in 3 quarters. The position peaked at $689K in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Scientech Research LLC reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 23,756 ADMA Biologics shares in Q2 2026, an estimated $214K.
  • Scientech Research LLC first reported a position in ADMA Biologics in Q2 2025 and held it in 3 quarters.
  • Scientech Research LLC's ADMA Biologics position peaked at $689K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.